Literature DB >> 20501926

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Brent M Egan1, Yumin Zhao, R Neal Axon.   

Abstract

CONTEXT: Hypertension is a major risk factor for cardiovascular disease and treatment and control of hypertension reduces risk. The Healthy People 2010 goal was to achieve blood pressure (BP) control in 50% of the US population.
OBJECTIVE: To assess progress in treating and controlling hypertension in the United States from 1988-2008. DESIGN, SETTING, AND PARTICIPANTS: The National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2008 in five 2-year blocks included 42 856 adults aged older than 18 years, representing a probability sample of the US civilian population. MAIN OUTCOME MEASURES: Hypertension was defined as systolic BP of at least 140 mm Hg and diastolic BP of at least 90 mm Hg, self-reported use of antihypertensive medications, or both. Hypertension control was defined as systolic BP values of less than 140 mm Hg and diastolic BP values of less than 90 mm Hg. All survey periods were age-adjusted to the year 2000 US population.
RESULTS: Rates of hypertension increased from 23.9% (95% confidence interval [CI], 22.7%-25.2%) in 1988-1994 to 28.5% (95% CI, 25.9%-31.3%; P < .001) in 1999-2000, but did not change between 1999-2000 and 2007-2008 (29.0%; 95% CI, 27.6%-30.5%; P = .24). Hypertension control increased from 27.3% (95% CI, 25.6%-29.1%) in 1988-1994 to 50.1% (95% CI, 46.8%-53.5%; P = .006) in 2007-2008, and BP among patients with hypertension decreased from 143.0/80.4 mm Hg (95% CI, 141.9-144.2/79.6-81.1 mm Hg) to 135.2/74.1 mm Hg (95% CI, 134.2-136.2/73.2-75.0 mm Hg; P = .02/P < .001). Blood pressure control improved significantly more in absolute percentages between 1999-2000 and 2007-2008 vs 1988-1994 and 1999-2000 (18.6%; 95% CI, 13.3%-23.9%; vs 4.1%; 95% CI, -0.5% to 8.8%; P < .001). Better BP control reflected improvements in awareness (69.1%; 95% CI, 67.1%-71.1%; vs 80.7%; 95% CI, 78.1%-83.0%; P for trend = .03), treatment (54.0%; 95% CI, 52.0%-56.1%; vs 72.5%; 95% CI, 70.1%-74.8%; P = .004), and proportion of patients who were treated and had controlled hypertension (50.6%; 95% CI, 48.0%-53.2%; vs 69.1%; 95% CI, 65.7%-72.3%; P = .006). Hypertension control improved significantly between 1988-1994 and 2007-2008, across age, race, and sex groups, but was lower among individuals aged 18 to 39 years vs 40 to 59 years (P < .001) and 60 years or older (P < .001), and in Hispanic vs white individuals (P = .004).
CONCLUSIONS: Blood pressure was controlled in an estimated 50.1% of all patients with hypertension in NHANES 2007-2008, with most of the improvement since 1988 occurring after 1999-2000. Hypertension control was significantly lower among younger than middle-aged individuals and older adults, and Hispanic vs white individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501926     DOI: 10.1001/jama.2010.650

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  783 in total

1.  New recommendations for treating hypertension in black patients: evidence and/or consensus?

Authors:  Jackson T Wright; Lawrence Y Agodoa; Lawrence Appel; William C Cushman; Anne L Taylor; Gbenga G Obegdegbe; Kwame Osei; James Reed
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

Review 2.  The health of homeless people in high-income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations.

Authors:  Seena Fazel; John R Geddes; Margot Kushel
Journal:  Lancet       Date:  2014-10-25       Impact factor: 79.321

3.  Medication non-adherence after myocardial infarction: an exploration of modifying factors.

Authors:  Matthew J Crowley; Leah L Zullig; Bimal R Shah; Ryan J Shaw; Jennifer H Lindquist; Eric D Peterson; Hayden B Bosworth
Journal:  J Gen Intern Med       Date:  2015-01       Impact factor: 5.128

4.  Arterial Stiffness and Hypertension - Which Comes First?

Authors:  Monica Ecobici; Claudiu Stoicescu
Journal:  Maedica (Bucur)       Date:  2017-09

5.  Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response.

Authors:  S Sud; C O'Callaghan; C Jonker; C Karapetis; T Price; N Tebbutt; J Shapiro; G Van Hazel; N Pavlakis; P Gibbs; M Jeffrey; L Siu; S Gill; R Wong; D Jonker; D Tu; R Goodwin
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

6.  Child health in the United States: recent trends in racial/ethnic disparities.

Authors:  Neil K Mehta; Hedwig Lee; Kelly R Ylitalo
Journal:  Soc Sci Med       Date:  2012-09-17       Impact factor: 4.634

7.  Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy.

Authors:  Keith C Ferdinand
Journal:  Cardiorenal Med       Date:  2012-10-26       Impact factor: 2.041

Review 8.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 9.  Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association.

Authors:  Carlos J Rodriguez; Matthew Allison; Martha L Daviglus; Carmen R Isasi; Colleen Keller; Enrique C Leira; Latha Palaniappan; Ileana L Piña; Sarah M Ramirez; Beatriz Rodriguez; Mario Sims
Journal:  Circulation       Date:  2014-07-14       Impact factor: 29.690

10.  Experimental Weight Gain Increases Ambulatory Blood Pressure in Healthy Subjects: Implications of Visceral Fat Accumulation.

Authors:  Naima Covassin; Fatima H Sert-Kuniyoshi; Prachi Singh; Abel Romero-Corral; Diane E Davison; Francisco Lopez-Jimenez; Michael D Jensen; Virend K Somers
Journal:  Mayo Clin Proc       Date:  2018-05       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.